Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 9121-9130 of 12128

Page
per page
  1. SBI-0640756
    BA3622 SBI-0640756
    Summary: SBI-0640756 (SBI-756) is an inhibitor.
  2. MC-Val-Cit-PAB
    BA2366 MC-Val-Cit-PAB
    Summary: MC-Val-Cit-PAB is a synthesized intermediate and is a toxin-Linker coupling (Drug-Linker Conjugates for ADC).
  3. Compound W
    A4401 Compound W
    Summary: γ-secretase inhibitor
      <39.63 mg/mL
  4. CP 471474
    A4435 CP 471474
    Summary: Broad spectrum MMP inhibitor
      <36.84 mg/mL
  5. DPPI 1c hydrochloride
    A4425 DPPI 1c hydrochloride
    Summary: DPP-IV Inhibitor
      <31.28 mg/mL
  6. Sal 003
    A4541 Sal 003
    Summary: Cellular phosphatase complex inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.15 mg/mL
  7. Floxuridine
    A2402 Floxuridine
    Target: Synthases/Synthetases
    Summary: Antineoplastic antimetabolite
      ≥12.31 mg/mL
  8. Camptothecin
    A2877 Camptothecin
     5 Citation
    Target: Topoisomerases
    Summary: Topoisomerase I inhibitor,prototypic
      insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL
  9. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL
  10. Prazosin HCl
    A5318 Prazosin HCl
    Summary: α1 and α2B-adrenoceptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥6.99 mg/mL

Items 9121-9130 of 12128

Page
per page